Condition: ABPA · Biologics · Allergic Bronchopulmonary Aspergillosis (ABPA) · Sponsor: Qianfoshan Hospital
To evaluate the efficacy and safety of biological agents in patients with allergic bronchopulmonary aspergillosis.
This description comes directly from the study's public registry record.
Qian Qi, Dr. · +86 13706380314 · qiqianqlh@163.com
Always discuss trial participation with your own doctor first.
| Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China | Jinan, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07362693